AgingResearch.NewsJoin free

Medical Enterprises

CompanyNetherlands

Medical Enterprises develops one asset, in phase 3 (Synergo RITE in bcg unresponsive bladder cancer). Mostly device; based in Netherlands.

1
Asset
Furthest stage
Phase 3
1
Trial
0
Signals

Pipeline

1

  • Synergo RITE

    Radiofrequency-induced bladder hyperthermia enhances the local effects of intravesical chemotherapy.

    Phase 3, Device, bcg unresponsive bladder cancer, bladder cancer

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Evidence behind the mechanisms1
  • Trials1
  • Similar companies1

Intelligence